novo nordisk cuts glp-1 drug prices for cash-paying customers. to Cut U.S. List Ozempic, Wegovy by Up to 50% Eli Lilly and Novo Nordisk

It is a legitimate commitment, and one you should make with full awareness of what the adjustment period looks like

Lilly's phase 2 results published in the New England Journal of Medicine show orforglipron achieved up to 14.7% mean weight reduction [press release]

L., & Trujillo, J

The news: In its Q3 earnings report, Novo Nordisk lowered its full year sales forecast for the third time this year as it continues to lose ground to Eli Lilly in obesity and diabetes

Current guidelines for the treatment of diabetes and obesity recommend a step-wise approach starting with lifestyle interventions aimed at body weight loss, an increase in physical activity, and additional measures for healthier choices in everyday decisions and habits

LIXIPARK, published in the New England Journal of Medicine in 2024, was the strongest result to date